20 March 2020 - Deborah Wilkes
Premium
Brazil’s Hypera Pharma has agreed to sell some of the Latin American products it is acquiring from Japan’s Takeda to Eurofarma Laboratorios for USD161 million.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.